Compound ID |
Compound Name |
Compound Formula |
CP0399659
|
(2R,3R)-2-(4-fluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C29H26F4N4O3
|
1
|
1 |
IC50 = 1 nM
|
|
|
CP0410890
|
(2R,3R)-2-(2,4-difluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C29H25F5N4O3
|
1
|
1 |
IC50 = 1 nM
|
|
|
CP0476835
|
(2S,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-pentan-3-yl-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C28H33F3N4O3
|
1
|
1 |
IC50 = 1 nM
|
|
|
CP0542514
|
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-(3-methylphenyl)-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C30H29F3N4O3
|
1
|
1 |
IC50 = 1 nM
|
|
|
CP0409974
|
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-[3-(trifluoromethyl)phenyl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C30H26F6N4O3
|
1
|
1 |
IC50 = 2 nM
|
|
|
CP0409975
|
(2R,3R)-2-(3,5-difluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C29H25F5N4O3
|
1
|
1 |
IC50 = 2 nM
|
|
|
CP0566534
|
(2R,3R)-2-(3,4-difluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C29H25F5N4O3
|
1
|
1 |
IC50 = 2 nM
|
|
|
CP0399658
|
(2S,3R)-3-(2,2-dimethylpropyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-pentan-3-ylbutanediamide
Show/Hide
|
C30H40N4O3
|
1
|
1 |
IC50 = 3 nM
|
|
|
CP0410889
|
(2R,3R)-2-(3-methyl-1,2-oxazol-4-yl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C27H26F3N5O4
|
1
|
1 |
IC50 = 3 nM
|
|
|
CP0476836
|
(2S,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(2-methylpropyl)-2-pentan-3-ylbutanediamide
Show/Hide
|
C29H38N4O3
|
1
|
1 |
IC50 = 3 nM
|
|
|
CP0428750
|
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-[3-(trifluoromethoxy)phenyl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C30H26F6N4O4
|
1
|
1 |
IC50 = 4 nM
|
|
|
CP0486923
|
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenyl-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C29H27F3N4O3
|
1
|
1 |
IC50 = 4 nM
|
|
|
CP0471072
|
(2R,3R)-2-(4-methoxyphenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C30H29F3N4O4
|
1
|
1 |
IC50 = 6 nM
|
|
|
CP0542515
|
(2S,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-propyl-3-(2,2,2-trifluoroethyl)butanediamide
Show/Hide
|
C25H27F3N4O3
|
1
|
1 |
IC50 = 24 nM
|
|
|
CP0472376
|
(2R,3R)-2-(1,2-oxazol-4-yl)-N'-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C25H22F3N5O4
|
1
|
1 |
IC50 = 29 nM
|
|
|
CP0481233
|
(2R,3R)-2-(5-methyl-1,2-oxazol-3-yl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C27H26F3N5O4
|
1
|
1 |
IC50 = 62 nM
|
|
|
CP0400691
|
(2R,3R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C26H25F3N6O4
|
1
|
1 |
IC50 = 119 nM
|
|
|
CP0399657
|
(2R,3R)-2-(1,3-oxazol-4-yl)-N'-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C25H22F3N5O4
|
1
|
1 |
IC50 = 161 nM
|
|
|
CP0381969
|
(2R,3R)-2-(1,2,4-oxadiazol-3-yl)-N'-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C24H21F3N6O4
|
1
|
1 |
IC50 = 656 nM
|
|
|
CP0480596
|
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-(3-methylsulfonylphenyl)-3-(3,3,3-trifluoropropyl)butanediamide
Show/Hide
|
C30H29F3N4O5S
|
1
|
1 |
IC50 = 2241 nM
|
|
|